HomeStyles-Adults of Chinese Heritage
HomeStyles: Shaping HOME Environments and LifeSTYLE Practices to Reduce Cardiometabolic Disease Risk in Adults of Chinese Heritage Living in the United States
2 other identifiers
interventional
400
1 country
1
Brief Summary
Individuals of Chinese heritage are the largest and fastest growing segment of the US Asian population. US Chinese have sociodemographic characteristics and culture that differ substantially from other US Asians, and therefore, differ in social determinants of health, health status, and disease risk. US Chinese adults are at increased risk for cardiometabolic disease, related conditions (obesity, type 2 diabetes mellitus, hypertension), and systemic inflammation that promotes disease onset and progression. Immigration to a new country can substantially impact the gut microbiome which may promote systemic inflammation. Pilot interventions indicate a high-fiber diet rich in whole grains reduced inflammation and improved obesity. Additionally, the United States Department of Agriculture (USDA) supported, evidence-based HomeStyles intervention has demonstrated feasibility, acceptability, and efficacy in improving lifestyle behaviors and home environments associated with obesity risk in families. A lack of linguistically, culturally tailored interventions to their specific health needs makes it difficult for US Chinese to implement healthy lifestyle behaviors and reduce health risks. Interventions tailored for US Chinese that could attenuate modifiable cardiometabolic risk factors, understand physiological sequelae, and bridge health equity are not currently available. Thus, the overall goal of this project is to test the efficacy of HomeStyles in improving health outcomes in US Chinese. Project aims are to: A) Culturally adapt the HomeStyles intervention through community-engaged approaches. B) Conduct a 10-week, 2-armed Randomized Controlled Trial (RCT) to test HomeStyles intervention efficacy on health outcomes (dietary intake, physical activity, self-efficacy, HbA1C, waist circumference, and BMI), hypothesizing that participants randomized to the treatment condition will have greater improvements in health outcomes than control comparators. C) Examine associations between intervention participation and gut microbiota/systemic inflammation and test hypotheses that a whole-grain rich diet adopted by those in the intervention group will increase anti-inflammatory gut bacteria, reduce inflammatory gut bacteria, and lower systemic inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedStudy Start
First participant enrolled
August 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
March 25, 2026
March 1, 2026
2.7 years
November 8, 2023
March 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Participant Health-related behaviors: Fruit/Vegetable/Fiber Intake (servings/day)
Dietary intake: Block Fruit/Vegetable/Fiber Screener servings/day; possible range 0 to infinity
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
Participant Health-related behaviors: Sugar-sweetened Beverage Intake (servings/day)
Dietary intake: HOMES Sugar-sweetened beverage Intake servings/day; possible range 0 to infinity
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
Participant Health-related behaviors: Physical Activity Level
Physical activity: Streamlined International Physical Activity Questionnaire; possible range 0 to 49; 49 is highest
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
Participant Health-related behaviors: Self-Efficacy for Health Behaviors
HOMES Self-Efficacy for Engaging in Healthy Cardiometabolic Behaviors; possible score range 1 to 5; 5 is highest
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
Participant Cardiometabolic Disease Markers: Diabetes Risk
HbA1c; percentage; normal below 5.7%; prediabetes 5.7 to 6.4%; diabetes 6.5% or above
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
Participant Cardiometabolic Disease Markers: Height (for BMI calculation)
Height (in cm)
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
Participant Cardiometabolic Disease Markers: Weight (for BMI calculation)
Weight (in kg)
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
Participant Cardiometabolic Disease Markers: Waist circumference
Waist circumference (in cm) for central adiposity assessment
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
Secondary Outcomes (15)
Participant Health-related Behavior: Sleep duration
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
Participant Cardiometabolic Disease Marker: Lipid
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
Participant Cardiometabolic Disease Marker: Inflammation
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition: Fruit/Vegetable/Fiber Intake (servings/day)
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition: Sugar-Sweetened Beverage Intake (servings/day)
Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)
- +10 more secondary outcomes
Study Arms (2)
Experimental: Healthy HomeStyles
EXPERIMENTALOnline educational intervention
Active Comparator: Safe HomeStyles
ACTIVE COMPARATOROnline educational intervention
Interventions
2-arm \~10 week educational intervention
Eligibility Criteria
You may qualify if:
- adult of Chinese heritage \>30 years with a self-reported cardiometabolic condition or living with an adult (spouse/partner, parent) with a cardiometabolic condition; primary food gatekeeper in the household (i.e., makes all or most decisions related to family food choices); has regular Internet access, read English and/or Chinese, and resides in New York/New Jersey metro area
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rutgers University
New Brunswick, New Jersey, 08901, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carol Byrd-Bredbenner
Rutgers University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- concurrent treatments different in subject matter but equal in nonspecific treatment effects
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Distinguished Professor of Nutrition
Study Record Dates
First Submitted
November 8, 2023
First Posted
November 18, 2023
Study Start
August 25, 2024
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
March 25, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- At the conclusion of the study after study data are published
- Access Criteria
- Request for data access to PI
Deidentified primary and secondary outcome data will be shared after study data are published and upon request